Dietary Omega-3 Fatty Acids as a Therapeutic Strategy in Insulin Resistant Humans
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Docosahexaenoic acid; Eicosapentaenoic acid
- Indications Insulin resistance
- Focus Pharmacodynamics; Therapeutic Use
- 03 Mar 2017 Biomarkers information updated
- 11 Apr 2013 New source identified and integrated (Mayo Clinic: 12-004590).
- 05 Apr 2013 Planned End Date changed from 1 Nov 2013 to 1 Jun 2014 as repored by ClinicalTrials.gov.